Follow
Uri Ben-David
Title
Cited by
Cited by
Year
The tumorigenicity of human embryonic and induced pluripotent stem cells
U Ben-David, N Benvenisty
Nature Reviews Cancer 11 (4), 268-277, 2011
10222011
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells
Y Mayshar, U Ben-David, N Lavon, JC Biancotti, B Yakir, AT Clark, K Plath, ...
Cell stem cell 7 (4), 521-531, 2010
8742010
Genetic and transcriptional evolution alters cancer cell line drug response
U Ben-David, B Siranosian, G Ha, H Tang, Y Oren, K Hinohara, ...
Nature 560 (7718), 325-330, 2018
7982018
Patient-derived xenografts undergo mouse-specific tumor evolution
U Ben-David, G Ha, YY Tseng, NF Greenwald, C Oh, J Shih, ...
Nature genetics 49 (11), 1567-1575, 2017
6812017
Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting
AJ Aguirre, RM Meyers, BA Weir, F Vazquez, CZ Zhang, U Ben-David, ...
Cancer discovery 6 (8), 914-929, 2016
6372016
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ...
Nature cancer 1 (2), 235-248, 2020
4962020
Context is everything: aneuploidy in cancer
U Ben-David, A Amon
Nature Reviews Genetics 21 (1), 44-62, 2020
4822020
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen
U Ben-David, QF Gan, T Golan-Lev, P Arora, O Yanuka, YS Oren, ...
Cell stem cell 12 (2), 167-179, 2013
3502013
Assessing the safety of stem cell therapeutics
CEP Goldring, PA Duffy, N Benvenisty, PW Andrews, U Ben-David, ...
Cell stem cell 8 (6), 618-628, 2011
2892011
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells
U Ben-David, Y Mayshar, N Benvenisty
Cell stem cell 9 (2), 97-102, 2011
2702011
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
OM Enache, V Rendo, M Abdusamad, D Lam, D Davison, S Pal, ...
Nature genetics 52 (7), 662-668, 2020
2052020
Genomic evolution of cancer models: perils and opportunities
U Ben-David, R Beroukhim, TR Golub
Nature Reviews Cancer 19 (2), 97-109, 2019
2032019
Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells
U Ben-David, G Arad, U Weissbein, B Mandefro, A Maimon, T Golan-Lev, ...
Nature communications 5 (1), 4825, 2014
1752014
Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells
U Ben-David, N Nudel, N Benvenisty
Nature communications 4 (1), 1992, 2013
1662013
Genome maintenance in pluripotent stem cells
U Weissbein, N Benvenisty, U Ben-David
Journal of Cell Biology 204 (2), 153-163, 2014
1572014
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Y Cohen-Sharir, JM McFarland, M Abdusamad, C Marquis, SV Bernhard, ...
Nature 590 (7846), 486-491, 2021
1502021
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies
JA Heslop, TG Hammond, I Santeramo, A Tort Piella, I Hopp, J Zhou, ...
Stem cells translational medicine 4 (4), 389-400, 2015
1342015
Landscape of genomic alterations in pituitary adenomas
WL Bi, P Horowitz, NF Greenwald, M Abedalthagafi, PK Agarwalla, ...
Clinical Cancer Research 23 (7), 1841-1851, 2017
1202017
Genomic instability in human pluripotent stem cells arises from replicative stress and chromosome condensation defects
N Lamm, U Ben-David, T Golan-Lev, Z Storchová, N Benvenisty, B Kerem
Cell stem cell 18 (2), 253-261, 2016
1202016
Assessing the safety of human pluripotent stem cells and their derivatives for clinical applications
PW Andrews, U Ben-David, N Benvenisty, P Coffey, K Eggan, ...
Stem cell reports 9 (1), 1-4, 2017
1162017
The system can't perform the operation now. Try again later.
Articles 1–20